Our findings provide basic information for the different expression of TLR4 via epigenetic modification of TLR4 promoter in various gastric cancer cells and the relationship between epigenetic modification and TLR4 expression may contribute to this regulation of these alterations results in enhanced levels of TLR4 that can confer responsiveness to anti-tumor drug. This evidence concerns the gene TLR4 and gastric cancer.